Peer Review History

Original SubmissionNovember 11, 2022
Decision Letter - Omar M Khraisat, Editor

PONE-D-22-31148Ref. KPB.B 1900/225/2565 11 December, 2022Validation of the depression, anxiety, and stress scales (DASS-21): among Thai nursing students in the online learning environment during the COVID-19 outbreak: A multi-center study.PLOS ONE

Dear Dr. summart,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 10,2023. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Omar M Khraisat, Associate Professor

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. During your revisions, please note that a simple title correction is required: Please remove the text "Ref. KPB.B 1900/225/2565 11 December, 2022" from the title on the online submission information.

3. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

4. Thank you for stating the following in the Acknowledgments/ Funding Section of your manuscript:

“The Walailak University's Individual Research Grants provided funding for the study (Grant Number WU-IRG-65-015).”

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

5. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

6. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. Under study design & Population: It is not clear how they recruit the participants in their study since the sample was taken from a larger multi-center survey, and how they randomize them.

2.Do the survey was part of the larger study, or after the larger study completed they recruit the sample and send them the survey of DASS-21

2. "To interpret these results is comparable to the original version of DASS-41 that calculated from the total scores for each sub-scale multiplying by two". This statement is not clear. & why they have used the 21 items scale since the original was 41 items?

3. Reference number 24 is retracted.

4. Based on what you have enrolled this number of participant (3705)? and you have mentioned that you need 5 – 10 participants for each item.

5. The exclusion criteria are not clear in the manuscript.

6. Fatigue (VAS-F) is different construct than anxiety and depression. So how it was used to test the convergent validity of the DASS-18.

7. It is not clear how randomization of the participants was done?

8. It was mentioned that the parellel analysis revealed a single factor, then a 3 factor solution was created. how this was run?

9. What was the factor loading for the deleted items and in which factors they loading(the rule is to retain items if they had a factor loading of 0.4 or more).

10. Did the total variance changed after you remove the three factors?

11. The title of Table 2 need to be changed to "The title of the table should be Exploratory Factor Analysis of the DASS-18"

12. in page 11 under the tittle Confirmatory factor analysis, the term "subscales" is used instead of "Items".. there is a big difference between both.

13. What was Composite Reliability (CR) of the three factors as an evidence of reliability.

14. What was the Average Variance Extracted (AVE) for the scales ? (this is considered a measure of convergent validity)

15. What is the relation of gender to convergent validity? Gender is not a scale. how you consider is an evidence of convergent validity?

16. Table 3 has a lot of errors & empty cells. besides, this is a correlation table not a Convergent and discriminant validity for the subscale of the DASS-18.

17. How did you measure the variable "Online Learning". it was mentioned in table 3.

18. some non scientific terms are used such as "directly linked".. "values were discovered to exist"." comparable discoveries"

19. I am not sure why table 5 was reported. it is a correlation table. they have already run the factor analysis.

20. How the temporal stability of the tool was measure. " the term is mentioned in page 13 under "Discussion".

21. There are some typing and grammatical errors in the manuscript.

22. How did the authors know that female had more depression? We can’t know that by simple running correlation. You need to do a T-test

23. The authors have mentioned in the discussion that "no effect on both the DASS-depression and DASS-anxiety scales as we found no significant cultural problems with those two scales and there was no concern with the EFA findings as demonstrated by the statistical results". I think this couldn’t attributed to cultural factors only. This depends on the responses of the participants

24. The authors have mentioned that "The Thai version's convergent validity is supported by favorable correlations with VAS-F dimensions; correlations in this direction were anticipated which were expected to measure the same construct" Actually they are measuring different constructs, so they came up with this conclusion?

25. the authors have reported that there is an evidence of concurrent validity but it is not clear how it was measured (278 anxiety and depression are used in the same tool, so it can't be considered a concurrent validity.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

For the reviewser' scomments, I am very appreciate for all comments because I have some error before you kindly comment our manuscript. Thanks for your good comments for me.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Omar M Khraisat, Editor

PONE-D-22-31148R1Validation of the depression, anxiety, and stress scales (DASS-21) among Thai nursing students in the online learning environment during the COVID-19 outbreak: A multi-center study.PLOS ONE

Dear Dr. summart,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 23 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Omar M Khraisat, Associate Professor

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Thank you for the opportunity to review this manuscript. The article reports the validation of the Depression, Anxiety, and Stress Scales (DASS-21) among Thai nursing students in the online learning environment during the COVID-19 outbreak. The topic holds significant importance for the nursing profession, considering the global impact of the COVID-19 pandemic. I particularly appreciate the inclusion of universities from various regions of Thailand in their study. I commend the authors for undertaking this research.

Please see my comments below for strengthening the manuscript:

Introduction: The introduction section could be written with more clarity and focus on the research gap. Some statements are too generic and require context and clarification of terms. I have detailed them below:

• The reference to Lee et al (2019) was used to support the statement about low performance at work or school, disruptions in social life, and even suicide, but the reference is a study evaluating the Depression Anxiety Stress Scales, which is not directly relevant. It would be helpful to provide more specific and relevant references to support these claims.

• The statement about "more than a third of nursing students" and almost 'one half of these students' would be unclear without the total number of nursing students in the context of the study. Clarifying the total number of nursing students would provide better context.

• It would be beneficial to provide a clear definition of 'remote learning' or 'online learning,' whichever terms the authors choose, to establish the context. Additionally, the terms "high intentions," "extensive training and learning processes" need further clarification and explanation.

• The article mentions a research article explaining the high risk of infection exposure and fear of transmitting diseases among students, but it is not clear how this relates to the study's context of 'remote learning'. The connection between remote learning and these factors needs to be clearly established.

• The sentence in line 42-43 requires evidence to support the claim made. It would be beneficial to provide supporting references or data to strengthen this statement.

• There should be a brief explanation of DASS, its psychometric properties, and the difference between DASS-21 and the original DASS scale. Justifying the use of DASS-21 in this study would enhance the manuscript.

• It is important to define the young adult age group being referred to in the study. Clarifying the specific age range would eliminate ambiguity and improve the precision of the research.

• Considering the Thai context during the COVID-19 outbreak/pandemic, it would be valuable to include relevant information about the situation in Thailand, particularly during the data collection phase from April to June 2022. Providing contextual information would enhance the understanding of the study's findings.

Study instruments: I was unsure how the process of translating the original version into Thai was conducted, as the reference was to a DASS Brunei version. It would be helpful to provide information on who conducted the translation, whether there was any back-translation, and the measures taken to ensure there was no loss of meaning in the translation and to ensure consistency and validity. Additionally, information on the reliability and validity of the selected instruments, including the VAS-F scale, should be provided. Was there any pilot testing of the translated version?

Sample size calculation: Information on the sample could have been better. Who were these nursing students? What kind of remote learning did they engage in, how many hours, and what courses were included? How were they recruited? It would also be helpful to clarify whether students with existing CMDs (Common Mental Disorders) were excluded or not.

Line 130 - (group 1, n= 2,000, and group 2, n= 1,706). The total should be 3,706. Please verify this.

Statistical analysis: Can you include the statistical software used? I wasn't clear which items were removed and how the study ended up using DASS-18. It was only explained later on under the subheading "Confirmatory factor analysis." It would be helpful to signpost the reader by mentioning that this would be discussed later on.

The results and discussion sections are generally well-written. However, the statement in Line 274-276 should elaborate more on cultural factors and draw on relevant literature to support the discussion. Additionally, in relation to this statement, I wasn't sure what was meant by "no significant cultural problems." It would be beneficial to provide further clarification or explanation to ensure understanding.

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #3: Yes: Emmanuel Z. Chona

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 2

Thank you for all of your comment to improve our manuscript. We attemp to edit and clearify all of the statements that you recommends however our revised manuscript is not completely edited. Please accept our apologize. We remain accetable for all of your suggestion.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Omar M Khraisat, Editor

Validation of the depression, anxiety, and stress scales (DASS-21) among Thai nursing students in the online learning environment during the COVID-19 outbreak: A multi-center study.

PONE-D-22-31148R2

Dear Dr.,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Omar M Khraisat, Associate Professor

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: No

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: I am pleased with the comprehensive revisions made in response to the comments. I would like to note that there is a discrepancy in line 144-5, where the total number is stated as 3,706 instead of 3,705 as mentioned elsewhere in the manuscript. Please double-check this inconsistency.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Omar M Khraisat, Editor

PONE-D-22-31148R2

Validation of depression, anxiety, and stress scales (DASS-21) among Thai nursing students in an online learning environment during the COVID-19 outbreak: a multi-center study.

Dear Dr. Summart:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Omar M Khraisat

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .